相关实验视频
Updated: Jun 14, 2025

07:04
Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
254
皮肤癌中PD-1的作用:分子机制,临床应用和耐药性
Neha Sharma1, Rupa Mazumder1, Pallavi Rai2
1Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida, Uttar Pradesh, India.
Chemical biology & drug design
|September 4, 2024
概括
这项研究研究了皮肤癌中编程细胞死亡蛋白1 (PD-1),详细介绍了它在免疫逃避和治疗潜力的作用. 它还解决了对PD-1抑制剂的抵抗机制,这对于改善皮肤癌治疗结果至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
背景情况:
- 皮肤癌,包括黑色素瘤,状细胞癌和基底细胞癌,是全球性的健康问题.
- 由于许多亚型的治疗能力有限,早期检测和治疗至关重要.
- 免疫检查点,特别是编程细胞死亡蛋白1 (PD-1),在瘤免疫逃避中发挥着关键作用.
研究的目的:
- 探索PD-1在皮肤癌病原和免疫调节中的功能.
- 评估PD-1抑制剂在治疗皮肤癌的临床疗效和挑战.
- 研究抗药性机制,并提出增强PD-1抑制剂治疗的策略.
主要方法:
- 对PD-1和皮肤癌的现有研究进行了全面的文献审查和分析.
- 检查了PD-1在免疫逃避中的作用背后的分子机制.
- 临床试验数据和涉及PD-1抑制剂的治疗策略的批判性评估.
主要成果:
- PD-1是瘤微环境中免疫反应的关键调节者,促进免疫逃避.
- PD-1 抑制剂对各种皮肤癌症具有显著的治疗潜力.
- 发展对PD-1抑制剂的耐药性是一个重大的临床挑战,具有不同的潜在机制.
结论:
- 了解PD-1的作用对于推进皮肤癌免疫疗法至关重要.
- 克服耐药性的策略对于最大限度地发挥PD-1向治疗的好处至关重要.
- 需要进一步的研究来优化PD-1抑制剂治疗,以改善皮肤癌患者的治疗结果.
相关概念视频
Skin Cancer
4.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.0K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Renewal of Skin Epidermal Stem Cells
2.5K
The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.5K

